Industry News

Telesta Therapeutics Inc. today announced that it has executed a binding Agreement, subject to shareholder approval, to be acquired by ProMetic Life Sciences Inc. for consideration of $0.14/ Telesta share, payable in freely tradable shares of ProMetic Life Sciences. The actual number of ProMetic shares payable per Telesta common share, will be calculated based on the 5- day volume-weighted average price of ProMetic shares, for the 5 days..."/>
Telesta Therapeutics Announces Execution of a Binding Purchase Agreement from ProMetic Life Sciences Inc.
Telesta Therapeutics Inc. today announced that it has executed a binding Agreement, subject to shareholder approval, to be acquired by ProMetic Life Sciences Inc. for consideration of $0.14/ Telesta share, payable in freely tradable shares of ProMetic Life Sciences. The actual number of ProMetic shares payable per Telesta common share, will be calculated based on the 5- day volume-weighted average price of ProMetic shares, for the 5 days immediately..."/>
Telesta Therapeutics Announces Execution of a Binding Purchase Agreement from ProMetic Life Sciences Inc.
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers, today announced that its clinical grade CryoStor freeze media has been incorporated into the manufacturing process for Invossa, a cell-mediated gene therapy for knee..."/>
BioLife Solutions' CryoStor® Integrated in Kolon Group's Cell-Mediated Gene Therapy for Osteoarthritis
Interpace Diagnostics Group, a company that provides clinically useful molecular diagnostic tests and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for better patient diagnosis and management, reported today that the Company has launched a new version of their AccuCEA™ product called " Insights" for Gastroenterologists who focus on diagnosing and treating..."/>
Interpace Diagnostics Launches New Product for Pancreatic Cancer Testing
ProMetic Life Sciences Inc. announced today that it has entered into a binding agreement for the acquisition of Telesta Therapeutics, Inc, by way of a plan of arrangement under the Canada Business Corporations Act. Under the terms of the Agreement, ProMetic will acquire all of the share capital of Telesta at a share price of $0.14 payable in ProMetic common shares. The number of common shares to be issued by ProMetic will be based on the..."/>
ProMetic announces agreement to acquire Telesta Therapeutics Inc. in all share transaction
ProMetic Life Sciences Inc. announced today that it has entered into a binding agreement for the acquisition of Telesta Therapeutics, Inc, by way of a plan of arrangement under the Canada Business Corporations Act. Under the terms of the Agreement, ProMetic will acquire all of the share capital of Telesta at a share price of $0.14 payable in ProMetic common shares. The number of common shares to be issued by ProMetic will be based on the..."/>
ProMetic announces agreement to acquire Telesta Therapeutics Inc. in all share transaction
Oculus Innovative Sciences, Inc., a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care, today announced it has received a new 510 clearance from the U.S. Food and Drug Administration for the company’ s new post-dermal-procedures product. Under the supervision of a healthcare professional, the product is intended for the removal of foreign material..."/>
Oculus Innovative Sciences Receives U.S. FDA Approval for New Post-Dermal-Procedures Product for Removal of Foreign Material Including Microorganisms
Piramal Enterprises partners with Bain Capital for stressed asset investment fund. Billionaire Ajay Piramal-led Piramal Enterprises Ltd on Tuesday said it is launching a $1 billion distressed asset investment platform in association with private equity fund Bain Capital Credit, reported Mint."/>
Deals Buzz: Piramal, Bain Capital to launch stressed asset investment fund [Mint, New Delhi]
NeuroVive Pharmaceutical AB, the mitochondrial medicine company, today announces that its Chief Operating Officer, Jan Nilsson leaves the company. The company is entering into a very important period and is expecting exciting developments during the fall. Over the past several months, the business strategy and organization have been re-oriented to optimize the way forward."/>
NeuroVive Pharmaceutical: NeuroVive’s Chief Operating Officer Jan Nilsson Leaves the Company
Pfizer’ s existing anti-infective portfolio Pfizer’ s focus on infectious disease and expertise in this category will help enable broader access to anti-infective portfolio Expected to enhance near-term revenue growth potential for Pfizer’ s Essential Health business. NEW YORK---- Pfizer Inc. today announced that it has entered into an agreement with AstraZeneca to acquire the development and commercialization rights to its late-stage small molecule..."/>
Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca
Clal Biotechnology Industries Ltd.. The US pharmaceutical giant has decided to acquire Medivation, a Nasdaq-listed company, for $14 billion in cash. The Medivation share price leaped 21% in yesterday's trading as a result."/>
Pfizer's Medivation acquisition boosts Clal Biotech [Globes, Tel Aviv, Israel]
Piramal Enterprises Ltd on Tuesday said it is launching a $1 billion distressed asset investment platform in association with private equity fund Bain Capital Credit. "Once finalized, the platform will invest capital directly into businesses and/or acquire debt of such businesses to drive sensible restructurings. The sponsors believe that there is an over $1 billion investing opportunity in this space over the next few years, "..."/>
Piramal Enterprises announces stressed asset investment fund with Bain Capital [Mint, New Delhi]
Aurobindo Pharma Ltd on Tuesday said fiscal first-quarter profit rose 24% on better sales of generic drugs in US and Europe. Net profit rose to Rs.585.5 crore in the quarter ended June compared to Rs.472.5 crore in the same period last year, while revenue grew 13% to Rs.3, 726 crore. While net profit was above analysts' estimates, revenue came in below expectations."/>
Aurobindo Pharma Q1 net profit rises 24% to Rs585 crore [Mint, New Delhi]
OraSure Technologies will get federal funding to develop a Zika test despite Congress' failure to allocate money to fight the mosquito-borne disease. The south Bethlehem diagnostics company announced Tuesday it had been awarded a contract for up to $16.6 million from the U.S. Department of Health and Human Services."/>
OraSure gets Zika funding [The Morning Call (Allentown, Pa.)]
Alexion Pharmaceuticals, one of the participants in the program."/>
Malloy calls First Five program a huge success for Connecticut [New Haven Register, Conn.]
The portable charging station [The San Diego Union-Tribune]
Hemispherx Biopharma Inc. said Tuesday that it has received approval of a new drug application in Argentina for its treatment for chronic fatigue syndrome. The Philadelphia-based biotechnology company said rintatolimod, which has the U.S. trade name Ampligen, will be marketed by GP Pharm, Hemispherx's commercial partner in Latin America. "We believe that rintatolimod is the first drug to receive approval for this indication anywhere in the world," Hemispherx said in a..."/>
BRIEF: Hemispherx's chronic fatigue syndrome drug approved for Argentina [The Philadelphia Inquirer]
Medivation for pounds sterling 10.7 bn. The deal follows months of speculation about possible suitors for San Francisco-based Medivation, which produces prostate cancer treatment Xtandi."/>
Pfizer raid on rival to spark takeovers in drugs sector [Daily Mail, London]
Universal Health Services, Inc. announced today that Steve Filton, Senior Vice President and Chief Financial Officer will present at the Baird 2016 Healthcare Conference in New York, NY, on Wednesday, September 7, 2016 at 4:20 p.m. ET. Filton will also be presenting at the Wells Fargo 2016 Healthcare Conference in Boston, MA on Thursday, September 8, 2016 at 9:20 a.m. ET. A live audio webcast of both presentations will be available on the..."/>
Universal Health Services, Inc. To Present At Two Upcoming Healthcare Conferences

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Consumer Discretionary474 Articles
Information Technology428 Articles
Financials390 Articles
Industrials283 Articles
Health Care242 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.